Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Illana Gozes

Showing results (1-10 of 220) with videos related to

Pageof 22
Sort By:
Journal of Molecular Neuroscience : MN|January 24, 2003
Tau as a drug target in Alzheimer's diseaseIllana Gozes
Journal of Molecular Neuroscience : MN|September 23, 2003
Neuroscience collaborations meeting report: the Israel Society for Neuroscience, and the Institute of Neurosciences, Mental Health and Addiction in Canada, first joint meeting, Sunday, Dec. 15, 2002, Eilat, IsraelIllana Gozes
Journal of Molecular Neuroscience : MN|October 22, 2014
Journal of molecular neuroscience: impacting our brainsIllana Gozes
Expert Opinion on Therapeutic Targets|May 17, 2007
The role of vasoactive intestinal peptide in neuroprotection: Professor Illana Gozes is interviewed by Emma QuigleyIllana Gozes
The EPMA Journal|December 4, 2012
Tau pathology: predictive diagnostics, targeted preventive and personalized medicine and application of advanced research in medical practiceIllana Gozes
European Journal of Human Genetics : EJHG|May 22, 2023
A novel genomic mutation in ADNP leading to intellectual disabilityIllana Gozes
Biological Chemistry|May 9, 2015
The cytoskeleton as a drug target for neuroprotection: the case of the autism- mutated ADNPIllana Gozes
Journal of Molecular Neuroscience : MN|January 19, 2005
Parkinson's and Alzheimer's diseases: protein aggregations and neuroprotectionIllana Gozes
Current Pharmaceutical Design|April 29, 2011
NAP (davunetide) provides functional and structural neuroprotectionIllana Gozes
Journal of Molecular Neuroscience : MN|September 21, 2016
The Future for Dementia Research: a Perspective from the Journal of Molecular NeuroscienceIllana Gozes
Pageof 22

Showing results (1-10 of 220) with videos related to

Sort By:
Pageof 22
Journal of Molecular Neuroscience : MN|January 24, 2003
Tau as a drug target in Alzheimer's diseaseIllana Gozes
Journal of Molecular Neuroscience : MN|September 23, 2003
Neuroscience collaborations meeting report: the Israel Society for Neuroscience, and the Institute of Neurosciences, Mental Health and Addiction in Canada, first joint meeting, Sunday, Dec. 15, 2002, Eilat, IsraelIllana Gozes
Journal of Molecular Neuroscience : MN|October 22, 2014
Journal of molecular neuroscience: impacting our brainsIllana Gozes
Expert Opinion on Therapeutic Targets|May 17, 2007
The role of vasoactive intestinal peptide in neuroprotection: Professor Illana Gozes is interviewed by Emma QuigleyIllana Gozes
The EPMA Journal|December 4, 2012
Tau pathology: predictive diagnostics, targeted preventive and personalized medicine and application of advanced research in medical practiceIllana Gozes
European Journal of Human Genetics : EJHG|May 22, 2023
A novel genomic mutation in ADNP leading to intellectual disabilityIllana Gozes
Biological Chemistry|May 9, 2015
The cytoskeleton as a drug target for neuroprotection: the case of the autism- mutated ADNPIllana Gozes
Journal of Molecular Neuroscience : MN|January 19, 2005
Parkinson's and Alzheimer's diseases: protein aggregations and neuroprotectionIllana Gozes
Current Pharmaceutical Design|April 29, 2011
NAP (davunetide) provides functional and structural neuroprotectionIllana Gozes
Journal of Molecular Neuroscience : MN|September 21, 2016
The Future for Dementia Research: a Perspective from the Journal of Molecular NeuroscienceIllana Gozes
Pageof 22